Profluent

Profluent is an AI-first protein design company that uses generative AI models and large-scale datasets to design and validate novel proteins for biomedicine and industrial applications. Its platform accelerates the development of genetic medicines, initially focusing on CRISPR systems, enabling a paradigm shift from accidental discovery to intentional design of proteins.


Buy Funded Startups lists

Funding Round:

Funding Amount: $35M

Date: 21-Mar-2024

Investors: Spark Capital, Insight Partners, Air Street Capital, angel investors from OpenAI, Salesforce, Octant Bio, and Google including Jeff Dean

Markets: Biomedicine, AI, Gene Editing, Biotechnology

HQ: Berkeley, California, United States

Founded: 2022

Website: https://www.profluent.bio/

LinkedIn: https://www.linkedin.com/company/profluent-bio

Twitter: https://twitter.com/ProfluentBio

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/profluent-bio

Pitchbook: https://pitchbook.com/profiles/company/517947-31


Leave a Comment